Effect of P-glycoprotein expression on outcome in the ewing family of tumors

Pediatric Hematology and Oncology

Volumn 18, Issue 5, 2001, Pages 325-334

  Perri, T ^a   Fogel, M ^a   Mor, S ^a   Horev, G ^a   Meller, I ^a   Loven, D ^a   Issakov, J ^a   Kollender, Y ^a   Smirnov, A ^a   Zaizov, R ^a   Cohen, I J ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Ewing sarcoma; Multidrug resistance (MDR); P glycoprotein (Pgp); Prognosis

Indexed keywords

GLYCOPROTEIN; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CHILD; EWING SARCOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NEUROECTODERM TUMOR; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION; RELAPSE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MALE; P-GLYCOPROTEIN; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA, EWING'S;

EID: 17844380242     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800101300312591     Document Type: Article

References (37)

1. Ewing sarcoma family of tumors: Ewing sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors
2. Intensive systemic chemotherapy in localized Ewing sarcoma in childhood: A historical trial
3. Ewing sarcoma of bone: Clinicopathologic aspects of 308 cases from the Intergroup Ewing Sarcoma Study
4. Therapy for localized Ewing sarcoma of bone
5. Long-term results in 144 localized Ewing sarcoma patients treated with combined therapy
6. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
7. Clinical significance of P-glycoprotein in multidrug resistance malignancies
8. Molecular mechanisms of drug resistance - Review
9. Multiple-drug resistance in human cancer
10. Pharmacology of drugs that alter multidrug resistance in cancer
11. Multidrug resistance in sarcomas of children
12. Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood
13. P-Glycoprotein expression in canine lymphoma
14. P-Glycoprotein expression in ovarian cancer cell line following treatment with cisplatin
15. Expression of multidrug resistance-related P-glycoprotein in neuroblastoma cells
16. Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response
17. Prognostic implication of immunodetection of P-glycoprotein in Ewing sarcoma
18. Immunohistochemical detection of P-glycoprotein in Ewing's sarcoma and peripheral primitive neuroectodermal tumors before and after chemotherapy
19. Expression of P-glycoprotein in small round cell tumors of childhood
20. MDR 1 gene expression: Evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas
21. Expression of multidrug-resistant gene in human tumors and tissues
22. Quantitative analysis of MDR-1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction
23. Expression of P-glycoprotein in soft tissue tumors of childhood. Correlation of treatment response
24. Expression of MDR-1/P-glycoprotein in human sarcomas
25. Expression of the MDR-I gene in bone and soft tissue sarcomas of adult patients
26. Heterogeneity of intermediate filament expression in human testicular seminomas
27. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections
28. Functional expression of MDR-1 in acute myeloid leukemia: Correlation with the clinical-biological, immunophenotypical, and prognostic disease characteristics
29. Functional Pgp expression in multiple myeloma patients at primary diagnosis and relapse or progressive disease
30. Comparison between anthracyclines and rhodamine 123 accumulation in chronic lymphoid leukemia: Effect of cyclosporin A and verapamil
31. P-Glycoprotein in human sarcomas
32. Increased expression of the multidrug-resistance gene in undifferentiated sarcoma
33. Expression of multidrug-resistance gene and clinical outcome in osteosarcomas
34. Protein kinase inhibitor-induced alterations of drug uptake, cell cycle and surface antigen expression in human multidrug-resistant (Pgp and MRP) promyelocytic leukemia HL-60 cells
35. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: Studies of the Southwest Oncology Group Leukemia Research Program
36. Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines